Kris R M, Hazan R, Villines J, Moody T W, Schlessinger J
J Biol Chem. 1987 Aug 15;262(23):11215-20.
The bombesin receptor present on the surface of murine and human cells was identified using 125I-labeled gastrin-releasing peptide as a probe, the cross-linking agent disuccinimidyl suberate, and sodium dodecyl sulfate gels. A clone of NIH-3T3 cells which possesses approximately 80,000 bombesin receptors/cell with a single binding constant of approximately 1.9 X 10(-9) M was used in these studies. In addition, we used Swiss 3T3 cells and a human glioma cell line which possesses approximately 100,000 and approximately 55,000 bombesin receptors/cell, respectively. Under conditions found optimal for binding, it is demonstrated that 125I-labeled gastrin-releasing peptide can be cross-linked specifically to a glycoprotein of apparent molecular mass of 65,000 daltons on the surface of the NIH-3T3 cells. Similar results were obtained when the cross-linked product was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing or non-reducing conditions. Moreover, the cross-linking reaction is specific and saturable and the 65,000-dalton polypeptide is not observed when the cross-linking experiments were performed with a NIH-3T3 cell line which is devoid of bombesin receptors. Interestingly, glycoproteins with apparent molecular weights of 75,000 were labeled specifically by 125I-labeled gastrin-releasing peptide when similar experiments were performed with Swiss 3T3 cells and with human glioma cell line GM-340. These different molecular weights may indicate differential glycosylation as treatment with the enzyme N-glycanase reduced the apparent molecular weight of the cross-linked polypeptide to 45,000. On the basis of these results it is concluded that the cross-linked polypeptides represent the bombesin receptor or the ligand-binding subunit of a putative larger bombesin receptor expressed on the surface of these cells.
使用125I标记的胃泌素释放肽作为探针、交联剂辛二酸二琥珀酰亚胺酯和十二烷基硫酸钠凝胶,鉴定了存在于小鼠和人类细胞表面的蛙皮素受体。在这些研究中使用了NIH-3T3细胞克隆,其每个细胞约有80,000个蛙皮素受体,单一结合常数约为1.9×10(-9)M。此外,我们还使用了瑞士3T3细胞和一种人类胶质瘤细胞系,它们分别每个细胞约有100,000个和约55,000个蛙皮素受体。在发现的最佳结合条件下,证明125I标记的胃泌素释放肽可以特异性地交联到NIH-3T细胞表面表观分子量为65,000道尔顿的糖蛋白上。当在还原或非还原条件下通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析交联产物时,获得了类似的结果。此外,交联反应具有特异性且可饱和,当用缺乏蛙皮素受体的NIH-3T3细胞系进行交联实验时,未观察到65,000道尔顿的多肽。有趣的是,当用瑞士3T3细胞和人类胶质瘤细胞系GM-340进行类似实验时,表观分子量为75,000的糖蛋白被125I标记的胃泌素释放肽特异性标记。这些不同的分子量可能表明糖基化存在差异,因为用N-聚糖酶处理会使交联多肽的表观分子量降低至45,000。基于这些结果得出结论,交联多肽代表了在这些细胞表面表达的蛙皮素受体或假定的更大蛙皮素受体的配体结合亚基。